Inventor

LAWRENCE R MICHAEL

US62 patents

⚠️ This page may combine multiple inventors who share the name “LAWRENCE R MICHAEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LAWRENCE R MICHAEL

BRISTOL MYERS SQUIBB CO

Inhibitors of microsomal triglyceride transfer protein and method

Inhibitors of microsomal triglyceride transfer protein and method

Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same

Nucleic acids encoding microsomal trigyceride transfer protein

α-phosphonosulfinic squalene synthetase inhibitors

Aryl dihydropyridinone and piperidinone MGAT2 inhibitors

Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method

Inhibitors of microsomal triglyceride transfer protein and method

Inhibitors of microsomal triglyceride transfer protein and method

Microsomal triglyceride transfer protein

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

Lactam compounds and their use as inhibitors of serine proteases and method

Heterocyclic CETP inhibitors

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor4 (PAR4) inhibitors for treating platelet aggregation

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

Aryl dihydropyridinones and piperidinone MGAT2 inhibitors

Aryl dihydropyridinones and piperidinone MGAT2 inhibitors

Aryl dihydropyridinones and piperidinone MGAT2 inhibitors

Heterocyclic CETP inhibitors

Amino-benzazoles as P2Y1 receptor inhibitors

Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof

Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia

Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same

Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same

Aryl dihydropyridinones and piperidinone MGAT2 inhibitors

Aryl dihydropyridinones and piperidinone MGAT2 inhibitors

Imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists

4-hydroxy-3-(heteroaryl)pyridine-2-one APJ agonists

Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions

Imidazothiadiazole derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

Method for preparing compounds employing solid phase synthesis and novel linker-resin

α-phosphonosulfonate squalene synthetase inhibitors and method

Apelin receptor agonists and methods of use

Apelin receptor agonists and methods of use

Aryl dihydropyridinones and piperidinone MGAT2 inhibitors

Amino-benzazoles as P2Y1 receptor inhibitors with pyridine ring and heterocyclic components

Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method

Inhibitors of microsomal triglyceride transfer protein and method

Methods of treating kidney failure, and/or improving or stablizing renal function using modified relaxin polypeptides

Treatment of fibrosis, cardiovascular disease and heart failure with modified relaxin polypeptides

Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereof

Method of treating cardiovascular disease and heart failure with modified relaxin polypeptides

Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation

(unassigned)

Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method

α-phosphonosulfonate squalene synthetase inhibitors

Methods of preparing α-phosphonosulfinate squalene synthetase inhibitors

Nestable, modular apparatus for synthesis of multiple organic compounds

Method for preventing or treating hypertriglyceridemia